Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aberrant expression and subcellular localization of laminin 332 in oral squamous cell carcinoma: Implications for invasive front assessment.

Medicina oral, patologia oral y cirugia bucal·2026

Same author

A Novel Herbal Nano-Based Ear Drop with <i>Ocimum gratissimum</i> Essential Oil: An Alternative Strategy for Managing Otomycosis.

Pharmaceutics·2026

Same author

Escalating Antifungal Resistance Among <i>Candida</i> Species in Reproductive-Age Women in Vietnam: Implications for Women's Health and Healthcare Systems.

Pathogens (Basel, Switzerland)·2026

Same author

Validated virtual screening models for identifying allosteric inhibitors of ATP-citrate lyase: the role of docking scores and protein-ligand interaction similarity in hit selection.

Molecular diversity·2026

Same author

Biosynthesis and Biological Properties of Nano-Silver from <i>Aspergillus terreus</i> Towards Antibacterial and Antitumor Applications.

Pharmaceutics·2026

Same author

Improved ADME Prediction by Multitask Pretraining on Predicted Data: Insights from the ASAP-Polaris-OpenADMET Blind Challenge.

Journal of chemical information and modeling·2025

Same journal

Mapping toxicity pathways of per- and polyfluoroalkyl substances using interpretable classification-based machine learning models.

SAR and QSAR in environmental research·2026

Same journal

Structure-based identification of inhibitory compounds targeting M32 metallocarboxypeptidase of <i>Leishmania donovani</i>.

SAR and QSAR in environmental research·2026

Same journal

Multiscale computational evaluation of marine fungal metabolites containing iminohydantoin-like scaffolds as anti-Alzheimer drug candidates.

SAR and QSAR in environmental research·2026

Same journal

Conformational landscapes and binding free energies of multitarget phytochemicals reveal molecular recognition mechanisms in colorectal cancer-associated proteins.

SAR and QSAR in environmental research·2026

Same journal

AI-driven QSAR modelling and virtual screening in the discovery of selective dopamine D<sub>2</sub> receptor ligands.

SAR and QSAR in environmental research·2026

Same journal

Integrating machine learning and pharmacogenomics for biomarker discovery, identification and prioritization of potential drug candidates in ovarian cancer.

SAR and QSAR in environmental research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 6, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights.

K-M Thai^1,2,3, D-T Pham⁴, T-M Ngo^2,3

¹University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.

SAR and QSAR in Environmental Research

|August 13, 2025

Summary

This summary is machine-generated.

Researchers identified novel selective inhibitors for monoamine oxidase B (MAO-B), crucial for Parkinson's disease treatment. Computational methods pinpointed four promising compounds with potential therapeutic benefits.

Keywords:

2D-QSAR MAO-B molecular docking molecular dynamic simulation pharmacophore

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: May 6, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Computational chemistry
Neuroscience
Drug discovery

Background:

Monoamine oxidase B (MAO-B) plays a critical role in dopamine metabolism and is a significant therapeutic target for Parkinson's disease.
Developing selective MAO-B inhibitors is essential to manage Parkinson's disease symptoms effectively.

Purpose of the Study:

To identify novel, selective MAO-B inhibitors using a comprehensive in silico approach.
To evaluate the binding affinity and stability of potential inhibitors through molecular dynamics and binding free energy calculations.

Main Methods:

A multi-stage computational workflow including 3D-pharmacophore modeling, 2D-QSAR, ADMET filtering, molecular docking, and molecular dynamics (MD) simulations.
MM/PBSA analysis was employed to calculate binding free energies for top-ranked compounds.
Screening was performed across diverse chemical databases (ZINC, DrugBank, TCM, UNPD).

Main Results:

Twenty-two top candidate compounds were selected based on docking scores and predicted selectivity against MAO-A.
Four compounds (ZINC21285023, ZINC79651118, ZINC58283019, and UNPD89644/crotafuran E) demonstrated stable binding and favorable interactions with key MAO-B residues (Cys172, Tyr435) after 200 ns MD simulations.
The identified compounds showed comparable or superior performance to safinamide, a known MAO-B inhibitor.

Conclusions:

The study successfully identified four potent and selective MAO-B inhibitors through advanced computational techniques.
These compounds represent promising candidates for further experimental validation and potential development as Parkinson's disease therapeutics.
The integrated in silico workflow provides a robust strategy for discovering novel drug candidates for neurodegenerative diseases.